Al Mayadeen English

  • Ar
  • Es
  • x
Al Mayadeen English

Slogan

  • News
    • Politics
    • Economy
    • Sports
    • Arts&Culture
    • Health
    • Miscellaneous
    • Technology
    • Environment
  • Articles
    • Opinion
    • Analysis
    • Blog
    • Features
  • Videos
    • NewsFeed
    • Video Features
    • Explainers
    • TV
    • Digital Series
  • Infographs
  • In Pictures
  • • LIVE
News
  • Politics
  • Economy
  • Sports
  • Arts&Culture
  • Health
  • Miscellaneous
  • Technology
  • Environment
Articles
  • Opinion
  • Analysis
  • Blog
  • Features
Videos
  • NewsFeed
  • Video Features
  • Explainers
  • TV
  • Digital Series
Infographs
In Pictures
  • Africa
  • Asia
  • Asia-Pacific
  • Europe
  • Latin America
  • MENA
  • Palestine
  • US & Canada
BREAKING
Trump: A full payload of BOMBS was dropped on the primary site, Fordow
US President Donald Trump on Truth Social: We have completed our very successful attack on the three Nuclear sites in Iran, including Fordow, Natanz, and Esfahan
Al Mayadeen's correspondent in Iran: Israeli attacks renewed on Isfahan, Kashan, and Qom
Al Mayadeen's correspondent in Iran: Loud explosions heard in the cities of Isfahan, Kashan, and Qom, with no reported injuries
Al Mayadeen's correspondent in Iran: Iranian air defenses have shot down an Israeli drone over the city of Tabriz in northwestern Iran
Al Mayadeen's correspondent in Iran: Iranian air defenses have shot down an Israeli drone over the city of Qom, south of the capital Tehran
Al Mayadeen's correspondent in Iran: An explosion reported in Tabriz near Imam Reza Hospital
Al Mayadeen's correspondent: A squadron of aircraft was heard flying over several Iraqi cities, likely Iranian drones
Al Mayadeen's correspondent: The US President is currently chairing a National Security Council meeting
Islamic endowments in occupied al-Quds: Occupation forces arrested two Al-Aqsa guards and raided the mosque's prayer halls

FDA approves new drug to treat Alzheimer's

  • By Al Mayadeen English
  • Source: Agencies
  • 7 Jan 2023 00:04
2 Min Read

The FDA approved Leqembi, also known as lecanemab, just days after the agency was heavily criticized in a congressional report for its approval of another Alzheimer's medicine, Aduhelm.

  • x
  • Signage is seen outside of the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, US. (REUTERS)
    Signage is seen outside of the Food and Drug Administration (FDA) headquarters in the US. (Reuters)

The US Food and Medicine Administration authorized a long-awaited new drug aimed to reduce cognitive deterioration in Alzheimer's patients on Friday.

The FDA approved Leqembi, also known as lecanemab, just days after the agency was heavily criticized in a congressional report for its approval of another Alzheimer's medicine, Aduhelm.

In September, preliminary findings from a Leqembi trial revealed that it delayed cognitive loss in Alzheimer's patients by 27% over an 18-month period.

Leqembi and Aduhelm "represent an important advancement in the ongoing fight to effectively treat Alzheimer's disease," the FDA said in a statement as quoted by AFP.

Related News

New blood biomarker can predict Alzheimer's disease

The FDA authorized both treatments using an accelerated process, which allows the US regulatory agency to expedite the approval of drugs for serious illnesses with unmet medical needs.

Sources reported on December 30 that the 2021 FDA's approval of an Alzheimer's drug called Aduhelm was "rife with irregularities" as an 18-month congressional investigation found an "atypical collaboration" between FDA regulators and Aduhelm manufacturer, Biogen. 

According to the probe, investigators found that the company intended to "make history" when it set an "unjustifiably high" initial yearly price of $56,000 for the drug.

This comes against the backdrop of criticism as the FDA is expected to decide on approving another drug for treating the disease in January.

The report also found that there was an unusually high amount of phone exchanges between company officials and FDA delegates.

Read next: Scientists develop new blood test for Alzheimer’s disease

  • FDA
  • Alzheimer
  • Leqembi
  • Alzheimer's medicine

Most Read

Bin Salman: Islamic world backs Iran in call to Pezeshkian

MBS says Islamic world backs Iran in call with Pezeshkian

  • MENA
  • 15 Jun 2025
Iran launches 9th wave of Op. True Promise 3, destroys IOF air defense

Iran launches 9th wave of Op. True Promise 3, destroys IOF air defense

  • MENA
  • 17 Jun 2025
Rescue team work at the site where a missile launched from Iran struck Tel Aviv, Israel, Monday, June 16, 2025 (AP)

Wave 12 of Operation True Promise 3 launched, Sejjil deployed: IRGC

  • Politics
  • 18 Jun 2025
Iran launches missile barrage to Tel Aviv, casualties reported

True Promise 3, wave 14: Tel Aviv targeted, casualties reported

  • Politics
  • 19 Jun 2025

Coverage

All
The Ummah's Martyrs

Read Next

All
Iran’s Bavar-373 air defense system on display during a military drill (Mehr News Agency)
Politics

Iran intercepts Israeli drones near Tehran, multiple cities

The Israeli Iron Dome air defense system fires to intercept missiles during an Iranian attack over Tel Aviv, Occupied Palestine, Sunday, June 15, 2025 (AP)
Politics

Iran warns aid to 'Israel' will be treated as aggression

US President Donald Trump arrives to board Air Force One at Joint Base Andrews, Friday, June 20, 2025, en route to Montclair, New Jersey (AP)
Politics

Trump, Erdogan made covert attempts to hold talks with Iran: Axios

Ansar Allah supporters surround a giant Iranian flag during an anti-US and anti-'Israel' weekly rally in Sanaa, Yemen, Friday, June 20, 2025 (AP)
Politics

US ships in Red Sea will be targeted if US attacks Iran: YAF

Al Mayadeen English

Al Mayadeen is an Arab Independent Media Satellite Channel.

All Rights Reserved

  • x
  • Privacy Policy
  • About Us
  • Contact Us
  • Authors
Android
iOS